Latest News about REGN
Recent news which mentions REGN
From Benzinga
From Motley Fool
From InvestorPlace
Insights Into Regeneron Pharmaceuticals's Performance Versus Peers In Biotechnology Sector
May 17, 2024
From Benzinga
From Motley Fool
Here's How Much You Would Have Made Owning Regeneron Pharmaceuticals Stock In The Last 10 Years
May 14, 2024
From Benzinga
From InvestorPlace
From InvestorPlace
From Benzinga
From Benzinga
Industry Comparison: Evaluating Regeneron Pharmaceuticals Against Competitors In Biotechnology Industry
May 02, 2024
From Benzinga
Tickers
REGN
From InvestorPlace
Here's How Much You Would Have Made Owning Regeneron Pharmaceuticals Stock In The Last 20 Years
May 02, 2024
From Benzinga
From Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
April 30, 2024
From Benzinga
AbbVie's Dermatitis Drug Shown 'Superior' To Sanofi/Regeneron's Dupixent In Head-To-Head Study
April 25, 2024
From Benzinga
2 Small-Cap Growth Stocks With Room To Run
April 24, 2024
From Motley Fool
From Benzinga
Amgen/AstraZeneca's Asthma Drug Tezspire Vs. Sanofi/Regeneron's Blockbuster Dupixent - Analyst Gives His Pick
April 17, 2024
From Benzinga
From Benzinga
Eye Drug Eylea Price Manipulation: Regeneron Faces US Justice Department Allegations Over Medicare Pricing Of Its Best-Selling Eye Drug
April 11, 2024
From Benzinga
Should You Sell This Stock Following a Regulatory Roadblock?
April 05, 2024
Tickers
REGN
From Motley Fool
5 Healthcare Stocks to Buy for 2024
April 02, 2024
From InvestorPlace
Here's How Much $100 Invested In Regeneron Pharmaceuticals 10 Years Ago Would Be Worth Today
April 01, 2024
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.